BECN1 and Cerebral ischemia: Per our findings, ST2-104 peptide pretreatment further reversed MCAO or glutamate induced enhancement of Beclin-1 and LC3II expression, suggesting that the protective function of ST2-104 peptide has a close relationship with autophagy inhibition in cerebral ischemia injury.